Twelfth EDCTP Forum

15–20 Jun 2025 | Kigali, Rwanda

Register
Register
Register

Monday, 16 June 2025 | 10:30 - 12:30

1.2 Parallel session: Optimising the implementation of malaria prevention and treatment strategies

Location:MH 2Track:Parallel Session

Presentations:

OA-570 - Effect of intermittent preventive treatment in school-age children on malaria incidence in above fifteen years old population in rural Burkina Faso

Serge Henri Zango, Clinical Research Unit of Nanoro/Research Institute for Health Sciences/ National Center for Scientific and Technological Research (URCN/IRSS/CNRST), Burkina Faso

OA-418 - Acceptability and feasibility of implementing perennial malaria chemoprevention integrated into EPI in Togo: lessons learned from the MULTIPLY project

Rodion Konu, Faculty of Health Sciences, Department of Public Health, University of Lomé, Center for Training and Research in Public Health, Togo

OA-429 - Cost-effectiveness of perennial malaria chemoprevention in children under two years of age delivered alongside the expanded program on immunization in Sierra Leone, Togo and Mozambique

Maria Martínez Domínguez, Barcelona Institute of Global Health (ISGlobal), Spain

OA-434 - Effects of dihydroartemisinin-piperaquine for malaria preventive treatment on antiretroviral drugs concentrations and associated factors in African pregnant women living with HIV

Linda Stöger, Barcelona Institute for Global Health (ISGlobal), Spain

OA-384 - Acceptability of dihydroartemisinin-piperaquine as malaria intermittent preventive treatment for pregnant women living with HIV in Southern Mozambique

Tacilta Nhampossa, Manhiça Health Research Center (CISM) - Manhiça Foundation (FM), Mozambique

OA-709 - Strengthening health systems through implementation support strategies: evidence from Kapolowe District, DRC

Tafadzwa Maseko, University of Antwerp, Belgium